VBVida Bliokas

Vida Bliokas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vida Bliokas has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of a Clinician and Lived Experience Peer Worker Co‐Led Aftercare Program on Suicide Risk Factors

    by Vida Bliokas, Laura Whiting, Sarah Liddle, Rebecca Sng, Atanas Janackovski

    Introduction: Individuals who attempt suicide are at a greater risk of future suicide. Aftercare programs that provide assertive follow‐up for individuals following a suicide attempt or at high risk for suicide are becoming increasingly recognized as a critical component of suicide prevention. Research evaluating aftercare programs that utilize the lived experience peer workforce is lacking. This study assessed change in factors associated with suicide risk in a clinician and peer worker co‐led community‐based aftercare program for people who had attended a hospital emergency department following a suicide attempt or for high risk of suicide. Methods: One‐hundred and sixty‐seven program participants (58.1% females, M age = 34.07) completed measures of hopelessness, thwarted belongingness, perceived burdensomeness, depression, anxiety, stress, psychological distress, and self‐reported suicide risk, at baseline and at week‐4. Results: Significant reductions were observed in hopelessness, thwarted belongingness, perceived burdensomeness, depression, anxiety, stress, and psychological distress (all p < 0.001). Self‐reported suicide risk did not significantly change. Conclusion: The findings provide preliminary support for the effectiveness of an aftercare program incorporating the lived experience peer workforce in mitigating factors associated with suicide risk. Future research utilizing larger samples, control groups and broader outcome measures is needed to confirm these results. Trials Registration: The study is part of a larger trial registered by the Australian New Zealand Clinical Trials Registry, number ACTRN12618001701213


  • The effect of anthocyanins through diet and supplementation on cognitive function in older adults: a multi-centre randomised controlled clinical trial

    by Vinicius Do Rosario, Karina Chan, Elnaz Lorzadeh, Henry Brodaty, K. J. Anstey, Katherine Kent, Steven Roodenrys, Vida Bliokas, Lyn Phillipson, Monique Francois, et al.

    Anthocyanins, a flavonoid subclass present in certain blue, purple and red fruits and vegetables, have potential neuroprotective properties due to their anti-inflammatory, antioxidant, and signalling effects.


  • Open Access

    The association of plasma glutamate with food addiction in individuals with major depressive disorder

    by Stephanie S. Römer, Theresa A. Larkin, Vida Bliokas, Asmahan Elgellaie, Susan J. Thomas


  • Open Access

    Results of a Codesign Process: A Cognition Screening Pathway for Inpatient and Outpatient Settings for Patients Who Are Facing or Have Undergone Lower Limb Amputation

    by Erinn Dawes, Lyndel Hewitt, Vida Bliokas, Val Wilson

    Background/Objectives: Cognition plays a major role in prosthetic rehabilitation success. The ability to identify patients who may have difficulty understanding and adapting to the rehabilitation process is beneficial for clinicians and patients to allow for targeted and appropriate therapy. The research aim was to codesign a process that facilitates routine cognitive screening into the amputee inpatient journey. Methods: A convenience sample of sixteen medical and allied health practitioners from one local health district undertook a codesign process over 10 months from March to November 2023. A combination of virtual and face-to-face data collection occurred. Each of the codesign meetings was audio recorded, following which transcription occurred. Transcripts were reviewed using thematic analysis-based techniques to capture themes and consensus within the group. Results: Two pathways were established for use within one local health district, allowing clinicians to measure the cognition of patients in both inpatient and outpatient settings either before or after they underwent amputation. The newly established pathways provide step-by-step guidance for clinicians, such as how to address contraindicators for testing and providing guidance for subsequent neuropsychological testing. The Montreal Cognitive Assessment (MoCA), both paper based and electronic based, was selected as the cognitive screening tool for implementation. Conclusions: Utilizing codesign as a method for generating a cognitive screening pathway for amputees was successful. The pathways generated should be reviewed for suitability for application in other health settings.

  • Open Access

    Assessing the effect of anthocyanins through diet and supplementation on cognitive function in older adults at risk for dementia: protocol for a randomised controlled trial

    by Vinicius Do Rosario, Elnaz Lorzadeh, Henry Brodaty, Kaarin J Anstey, Karina Chan, Steven Roodenrys, Katherine Kent, Vida Bliokas, Lyn Phillipson, Katrina Weston-Green, et al.

    Introduction Promising evidence is emerging for the procognitive, anti-inflammatory and neuroprotective properties of dietary flavonoids, particularly anthocyanins that provide red, purple and blue plant pigments. Methods and analysis The ‘Food for Thought’ study is a multicentre, 6-month randomised, parallel 3-arm clinical trial. Its primary aim is to investigate whether anthocyanin consumption, either through diet or supplementation, can prevent memory loss progression and improve inflammatory and cardiovascular health in older adults at risk for dementia. Eligible participants will include those aged 60–85 years with a diagnosis of amnestic mild cognitive impairment or with a self-referral of memory concerns and scoring ≤13 on the Memory Index Score within the Telephone Montreal Cognitive Assessment screening test. Participants will be randomised to one of three arms: High anthocyanin (‘purple foods’) diet (aiming for a target of 250 mg anthocyanins/day); freeze-dried product derived from blackcurrants (250 mg anthocyanins/day); or control (coloured maltose powder). The primary outcome is auditory anterograde memory functioning assessed by the Buschke and Grober Free and Cued Selective Reminding Test-Immediate Recall. Secondary outcomes are additional cognitive functions including processing speed, working memory, aspects of executive functioning (attentional shifting and word generativity) and premorbid estimate as well as subjective memory problems and self-reported depression symptoms. Additional secondary outcomes are blood pressure, inflammatory biomarkers, brain-derived neurotrophic factor, fatty acid profile, apolipoprotein E and polyphenol metabolites, gut microbiota composition and function and vascular and microvascular endothelial function tests. Repeated measures analysis of variance and/or mixed linear modelling will evaluate changes over time, with the inclusion of covariates. Ethics and dissemination Ethics approval has been obtained from the Greater Western Human Research Ethics Committee (2021/ETH12083). A Consumer Advisory Group was established to guide and review the protocol and dissemination strategy. The results of this trial are intended to be published in a peer-reviewed journal. Trial sponsor National Health and Medical Research Centre Dementia Collaborative Research Centre. Start date of clinical trial: 02 September 2022. Expected end date: 11 October 2024. Trial registration number ACTRN12622000065796.


  • Open Access

    An investigation of allied health and medical clinicians’ viewpoint on prosthetic rehabilitation and cognition

    by Erinn Dawes, Vida Bliokas, Lyndel Hewitt, Val Wilson

    PurposeTo explore the factors that influence clinicians (occupational therapists, physiotherapists, vascular surgeons, and rehabilitation medicine physicians) when prescribing prosthetic rehabilitation. Additionally, the study aimed to gain insight into clinicians' perspectives regarding the role of patient cognition in prosthetic rehabilitation.Materials and methodsThis research constitutes one segment of a broader action research study which was undertaken in 2022. A total of thirty-four key clinicians involved in the amputation and prosthetic rehabilitation pathway within a local health district in Australia were engaged through a combination of group and individual interviews as well as surveys.ResultsFive essential considerations when prescribing prosthetic rehabilitation emerged. These included patient's goals, medical history, quality of life, cognitive abilities, and the support available on discharge. This study also revealed variations in opinions among different disciplines concerning appropriateness of prosthetic rehabilitation for the patient cohort. Despite this, there was a desire to build a consensus around a shared approach of identification for patients and clinicians.ConclusionThe identification of these key pillars for clinician consideration has simplified a complex area of care. These pillars could be used to guide pertinent conversations regarding prosthetic rehabilitation and are closely linked with the patient's cognition. Five key areas should be considered when prescribing prosthetic rehabilitation; patients' goals, medical history, quality of life, cognitive abilities and supports available on discharge.Qualitative findings show different clinician domains hold very different perspectives on the suitability of patients to receive a prosthesis and undergo prosthetic rehabilitation.Occupational therapists and rehabilitation medicine clinicians most frequently view patients as suitable to undergo prosthetic rehabilitation, followed by physiotherapists and finally vascular surgeons.Vascular surgeons view most patients' complex vascular medical history as a reason why only certain (younger) patients should undergo prosthetic rehabilitation.Communication of expectations between all members of the treating team is paramount for patient outcomes.


  • Food addiction, hormones and blood biomarkers in humans: A systematic literature review

    by Stephanie Sophie Römer, Vida Bliokas, Jillian Terese Teo, Susan J. Thomas


  • Cognitive screening in persons with an amputation: A retrospective medical record audit

    by Erinn Dawes, Vida Bliokas, Lyndel Hewitt, Val Wilson

    Objective: To determine the rate of cognitive screening undertaken with patients undergoing amputation and to determine the demographics of the sample. Study design: Retrospective medical record audit. Methods: The medical records of a convenience sample of persons who had undergone amputation, upper and lower limb, from one local health district were reviewed. The sample date range was between January 1st, 2017, and December 31st, 2018. The incidence and type of cognitive screening were also recorded. Descriptive statistics were used to describe the results. Results: A total of 178 episodes of amputation care were identified during retrospective medical record auditing (mean age, 69.7 years). Thirty nine of the 178 (21.9%) episodes of care had a cognitive screening measure completed during that inpatient admission (24.2% vascular etiology and 12% nonvascular etiology). All cognitive screens were completed in persons with lower-limb amputations and were completed postoperatively. Conclusion: Cognitive screening is not a routine part of the health care journey for patients with an amputation in this health care district.


  • Taking the next step: A qualitative study examining processes of change in a suicide prevention program incorporating peer-workers.

    by Brooke Van Zanden, Vida Bliokas

    Suicide is a leading preventable cause of death (Centers for Disease Control and Prevention, 2018). Recent research identifies the time following hospital discharge after a suicide attempt as a critical window whereby suicide risk is heightened. As a result, suicide aftercare services that emphasize timely follow-up intervention are increasingly popular. There is a lack of research exploring the role of peer-workers in the context of suicide prevention aftercare. This is surprising given that peer-work has been hypothesized to promote belongingness, engagement, and hope; all factors theorized as critical to suicide ideation and behavior. This project aimed to address this research gap by exploring the perspectives of six peer-workers and five clinicians (n = 11) employed in a suicide prevention aftercare program. Qualitative data were collected via an online survey and telephone interviews. Interviews explored what processes were perceived by peer-workers and clinicians as critical in facilitating change within the context of a suicide prevention service. Thematic analysis identified four themes encapsulating factors that promote change: (1) utilizing lived experience; (2) emotional availability of peers; (3) building lives worth living; and (4) consumer driven care. Our analysis also identified an additional, but less direct, mechanism of change: Consultation in the context of risk. Our findings show that peer-work in suicide prevention is regarded as largely positive by both peer-workers and clinicians. Peer-workers and clinicians highlighted the importance of collaboration and consultation to facilitate effective management of risk and supervision given the complex nature of suicide prevention work. Finally, workers emphasized the importance of promoting agency amongst service-users, which they viewed as particularly important within the context of suicide prevention. Implications for suicide prevention services are discussed.